Mehrbod Vakhshoori1, Maryam Heidarpour2, Davood Shafie1, Marzieh Taheri3, Nima Rezaei4,5,6, Nizal Sarrafzadegan7. 1. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. 2. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 3. Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. 4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. 5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 6. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. 7. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) has been widespread since late December 2019, with several symptoms related to the upper and lower respiratory system. However, its cardiac manifestations are less frequently studied. We aimed to analyze the available COVID-19 data on acute cardiac injury, using troponin and brain natriuretic peptide (BNP) levels. METHODS: We performed a systematic review on Medline/PubMed, Scopus, and Google Scholar databases until March 25, 2020. Relevant records reporting the incidence of acute cardiac injury as well as troponin and BNP levels were collected from published peer-reviewed articles with further analysis according to the clinical status of the patients (severe, non-severe, and death). RESULTS: Eleven records of 1394 individuals were included. The mean age of patients with acute cardiac injury was 56.6 ± 33.4 years (males: 54.3%). The incidence of acute cardiac injury was 15% (95% CI: 11, 20%). Further analysis revealed that dead or severe patients had significantly higher percentages of myocardial injury, compared to non-severe ones (peer-reviewed: 44%, 95% CI: 16, 74% vs. 24%, 95% CI: 15, 34% vs. 5%, 95% CI: 1, 12%, respectively). Mean total troponin was 10.23 pg/mL (95% CI: 5.98, 14.47), while 13% (95% CI: 8%, 18%) of patients had elevated levels. Mean BNP was 216.74 pg/mL (95% CI: 3.27, 430.20). CONCLUSION: Acute cardiac injury in COVID-19 patients is more frequent than what was expected at the beginning of the outbreak. Meanwhile, further studies are needed to investigate the utility of cardiac biomarkers as diagnostic and prognostic tools for long-term cardiac complications of this infection.
BACKGROUND:Coronavirus disease 2019 (COVID-19) has been widespread since late December 2019, with several symptoms related to the upper and lower respiratory system. However, its cardiac manifestations are less frequently studied. We aimed to analyze the available COVID-19 data on acute cardiac injury, using troponin and brain natriuretic peptide (BNP) levels. METHODS: We performed a systematic review on Medline/PubMed, Scopus, and Google Scholar databases until March 25, 2020. Relevant records reporting the incidence of acute cardiac injury as well as troponin and BNP levels were collected from published peer-reviewed articles with further analysis according to the clinical status of the patients (severe, non-severe, and death). RESULTS: Eleven records of 1394 individuals were included. The mean age of patients with acute cardiac injury was 56.6 ± 33.4 years (males: 54.3%). The incidence of acute cardiac injury was 15% (95% CI: 11, 20%). Further analysis revealed that dead or severe patients had significantly higher percentages of myocardial injury, compared to non-severe ones (peer-reviewed: 44%, 95% CI: 16, 74% vs. 24%, 95% CI: 15, 34% vs. 5%, 95% CI: 1, 12%, respectively). Mean total troponin was 10.23 pg/mL (95% CI: 5.98, 14.47), while 13% (95% CI: 8%, 18%) of patients had elevated levels. Mean BNP was 216.74 pg/mL (95% CI: 3.27, 430.20). CONCLUSION: Acute cardiac injury in COVID-19patients is more frequent than what was expected at the beginning of the outbreak. Meanwhile, further studies are needed to investigate the utility of cardiac biomarkers as diagnostic and prognostic tools for long-term cardiac complications of this infection.
Authors: Brandon Michael Henry; Maria Helena Santos de Oliveira; Isaac Cheruiyot; Justin Benoit; James Rose; Emmanuel J Favaloro; Giuseppe Lippi; Stefanie Benoit; Naomi Pode Shakked Journal: Mediators Inflamm Date: 2022-04-22 Impact factor: 4.529
Authors: Mehmet Yilmaz; Şerif Aksin; Deniz Balsak; Fazil Avci; Osman Özdoğru; Bekir Helvacıoğlu; Mahmut Erdemoğlu; Yasemin Aboalhasan; Gülsüm Doğan Journal: Int J Clin Pract Date: 2022-09-22 Impact factor: 3.149
Authors: Michael Y Henein; Giulia Elena Mandoli; Maria Concetta Pastore; Nicolò Ghionzoli; Fouhad Hasson; Muhammad K Nisar; Mohammed Islam; Francesco Bandera; Massimiliano M Marrocco-Trischitta; Irene Baroni; Alessandro Malagoli; Luca Rossi; Andrea Biagi; Rodolfo Citro; Michele Ciccarelli; Angelo Silverio; Giulia Biagioni; Joseph A Moutiris; Federico Vancheri; Giovanni Mazzola; Giulio Geraci; Liza Thomas; Mikhail Altman; John Pernow; Mona Ahmed; Ciro Santoro; Roberta Esposito; Guillem Casas; Rubén Fernández-Galera; Maribel Gonzalez; Jose Rodriguez Palomares; Ibadete Bytyçi; Frank Lloyd Dini; Paolo Cameli; Federico Franchi; Gani Bajraktari; Luigi Paolo Badano; Matteo Cameli Journal: J Clin Med Date: 2021-12-14 Impact factor: 4.241